SLRN - Acelyrin Inc. Net earnings per share (EPS TTM)

Symbol and logo of brand ACELYRIN (SLRN)

Analyzing the chart in GURU.Markets, we note volatility in the rolling annual earnings per share for Acelyrin, Inc. (SLRN), where the figure stands at -2.70. This price action reflects the development of selective therapies for skin and joints. Growth is driven by isobelibag trials and potential licensing agreements, while operations remain strictly limited by FDA medical regulations regarding the disposal of biomaterials.

SLRN (Acelyrin, Inc.) Net earnings per one share for the last twelve months history from 02/21/2024 to 05/31/2025

Summary analytical data breakdowns for Acelyrin Inc. (SLRN)

- share price and expert price forecast:
Stock Quotes Acelyrin, Inc.|SLRN - Analyst Forecast Prices
- market capitalization statistics:
Market Capitalization Acelyrin, Inc.|SLRN - Value Adjusted for Debt and Cash
- business book valuation details:
Book Value per Share ACELYRIN|SLRN - Total Stockholders' Equity|Market Value to Book Value Ratio acelyrin.com|SLRN - Aggregate Asset Value
- debt obligations and liquidity statistics:
Total Debt to Capital Acelyrin, Inc.|SLRN - Long-Term Debt to Capital|Short-Term Debt to Capital ACELYRIN, Inc.|SLRN - Company Total Debt|Debts to Book Capitalization Acelyrin, Inc.|SLRN - Long-Term Debt|Company Short-Term Debt ACELYRIN|Quick Liquidity Indicator acelyrin.com
- net income and valuation multiples indicators:
SLRN - Company Net Income|Expected Profit Acelyrin, Inc.|SLRN - Company Value to Net Income|Forward P/E Multiple ACELYRIN|SLRN - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Acelyrin, Inc.|SLRN - Operating profit before amortization|Net earnings per share for the last 12 months ACELYRIN|SLRN - Earnings per share for the trailing year|Quarterly EPS earnings growth acelyrin.com|SLRN - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year Acelyrin, Inc.
Initial company analysis:Acelyrin, Inc. (SLRN)
Manufactured products of Acelyrin Inc.

Net income per share over 12 months measures the portion of total income attributable to a single security. This metric is calculated by dividing the total trailing twelve-month profit by the current number of shares outstanding. Analyzing this chart of net income per share over the last 12 months allows for an assessment of capitalization efficiency. For Acelyrin, Inc. (SLRN), this price action confirms business resilience within an autonomous product cycle. Innovative developments make the company a reliable defensive asset, independent of global macroeconomic fluctuations.

Main competitors

HLN: Net earnings per share for the last 12 months|kenvue.com - Earnings per share for the last four quarters|VRNA: Net earnings per share (EPS TTM)|Jyong Biotech Limited - Earnings per share for the trailing year|LGND (Ligand Pharma) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Amneal Corp AMRX|Earnings per share for the last twelve months Perrigo Company plc (PRGO)|ALVO (alvotech.com) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) LQDA (Liquidia)|Net earnings per share (EPS TTM) Galapagos N.V. GLPG|ANI Pharma - Net earnings per share (EPS TTM)|Afrezza (MNKD) - Net earnings per share for the last 12 months|AMPH: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months pacira.com (PCRX)|Earnings per share for the last twelve months ARS Pharmaceuticals, Inc.|Earnings per share for the last twelve months TBPH|Net earnings per share for the last 12 months AQST (Aquestive Pharma)|SCPH - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months Tectonic Therapeutic TECX|Earnings per share for the trailing year TNXP|SXT China - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Eupraxia Pharmaceuticals EPRX|BioHarvest (BHST) - Earnings per share for the last twelve months|Earnings per share for the last 12 months EXOZ|Net earnings per share for the last 12 months ORMP|ENTX: Earnings per share for the trailing year|Net earnings per share (EPS TTM) HYFT|Net earnings per share for the last four quarters ABVC BioPharma Inc.|Earnings per share for the last twelve months Cumberland Pharma CPIX|QNTM: Earnings per share for the last 12 months|FibroGen, Inc. - Net earnings per share (EPS TTM)|telomirpharma.com (TELO) - Net earnings per share for the last 12 months|RANI (ranitherapeutics.com) - Net earnings per share for the last 12 months|SNYR - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Rallybio Corp|Lexaria (LEXX) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Pulmatrix, Inc. (PULM)|Earnings per share for the last twelve months PTHL (ftzy.com.cn)|Earnings per share for the last twelve months Aptorum Group APM|Earnings per share for the trailing year LYRA|IBO - Earnings per share for the last twelve months|TNFA (TNF Pharmaceuticals) - Earnings per share for the last 12 months|cbdmd.com (YCBD) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months PRFX (painreform.com)|CYTO (Altamira Therapeutics Ltd) - Net earnings per share (EPS TTM)|LIPO: Earnings per share for the trailing year|Net earnings per share (EPS TTM) OPTN|Net earnings per share (EPS TTM) Pieris Pharma (PIRS)|Earnings per share for the last twelve months Procaps Group S.A. PROC|Earnings per share for the trailing year PTPI|QLI - Earnings per share for the last twelve months|TFF Pharmaceuticals Inc. (TFFP) - Net earnings per share for the last 12 months